+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Anatomic Pathology Market Size ,Share & Trends Analysis Report By Application (Disease Diagnosis, Drug Discovery & Development), By Product & Services (Instruments, Consumables), By End Use, And Segment Forecasts, 2019 - 2025

  • ID: 4827928
  • Report
  • July 2019
  • Region: Global
  • 194 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bio SB
  • BioGenex
  • Cardinal Health
  • Dianon Systems, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sakura Finetek USA, Inc
  • MORE
The global anatomic pathology market size is expected to reach USD 23.3 billion by 2025, exhibiting a CAGR of 6.1% during the forecast period, according to this report. The advent of technology in instruments and protocols used during anatomic pathology is anticipated to increase the adoption rate of advanced anatomic pathological instruments.

Integration of medical informatics standards for meeting specific healthcare needs by enhancing efficiency and curbing costs is a factor driving the market. Market players are collaborating for refurbishment of pathology laboratories by incorporating innovative disease diagnostic models. This, in turn, accelerates investments toward upgradation of pathological equipment.

In April 2018, Thermo Fisher and Leica Microsystems collaborated for the development of an integrated cryo-tomography workflow for research. Under this collaboration, the companies merged their existing technology to deliver enhanced user-friendly and reliable microscopic solutions, enabling researchers to gain insights about biological processes.

Pathology-training programs offered to pathologist trainees by public and private entities drive the anatomic pathology market. The Royal College of Pathologists, the General Medical Council, and the Association of Anatomical Pathology Technology are some organizations that have initiated several training programs and examinations to evaluate a pathologist’s knowledge and skills.

Further key findings from the report suggest:
  • Technological advancements in instruments to minimize the risk of errors through integration of novel design is expected to drive the segment to register the fastest growth rate
  • High availability, low cost, and frequent purchase rate of consumables such as reagents and probes have attributed to the dominant revenue share of consumables
  • Increased implementation of anatomic pathology procedures in research studies such as tumor examination and biomarker profiling has propelled the academic research segment
  • Shifting paradigm from conventional medicine to personalized medicine has resulted in the fastest growth rate of the drug discovery and development application segment. This is primarily due to growing reliance on discoveries of putative biomarkers for development of personalized therapies
  • Increase in hospitalization rate that stimulates the adoption of pathological workflows for disease monitoring and diagnosis has contributed to the largest share of hospitals
  • On the other hand, growth of the diagnostic laboratories segment is facilitated by the use of state-of-the-art laboratory equipment and instrumentation, multiple electronic interfaces, and information systems
  • Presence of key players like Thermo Fisher and Agilent, coupled with a large number of funding programs by public agencies, contribute to the largest share of North America
  • Asia Pacific is expected to exhibit the fastest anatomic pathology market growth driven by the presence of multiple associations that are engaged in conducting pathology training programs
  • Competitors are adopting strategic initiatives such as installation of products, agreement, and expansion of distribution channels to reinforce their market presence. For instance, in July 2018, Thermo Fisher installed its Krios Cryo-TEM electron microscope at the Institut Pasteur, which expanded the company’s presence in France.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bio SB
  • BioGenex
  • Cardinal Health
  • Dianon Systems, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sakura Finetek USA, Inc
  • MORE
Chapter 1 Executive Summary
1.1 Anatomic Pathology Market Outlook, 2014 - 2025
1.2 Anatomic Pathology Segment Outlook, 2014 - 2025
1.3 Anatomic Pathology Competitive Insights, 2014 - 2025
1.4 Market Snapshot

Chapter 2 Research Methodology
2.1 Information Procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation

Chapter 3 Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market driver analysis
3.1.1.1 Implementation of biomarker-based disease assessments
3.1.1.2 Rising competitiveness among the market vendors
3.1.1.3 Substantial number of supporting programs and training modules by government
3.1.1.4 Increasing incidence of chronic disorders
3.1.2 Market restraint analysis
3.1.2.1 Stringent government regulations pertaining to anatomic pathology
3.1.2.2 Cognitive or identification errors in anatomic pathology analytic processes
3.2 Penetration & Growth Prospect Mapping For Anatomic Pathology Instruments, 2018
3.3 Anatomic Pathology Market-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis - Porter’s
3.5 Anatomic Pathology Application in Clinical Trials
3.6 Anatomic Pathology Market: Patent Analysis
3.7 Reimbursement Framework: Anatomic Pathology
3.8 Anatomic Pathology Market Regulatory Insights
3.9 Anatomic Pathology Market : User Perspective Analysis
3.9.1 Consumer behaviour analysis
3.10 Anatomic Pathology Market : Procedure Cost Analysis
3.11 Anatomic Pathology Market : Technology Timeline
3.12 Major Deals & Strategic Alliances Analysis
3.12.1 Agreement
3.12.2 Technology collaborations
3.12.3 Merger & acquisition
3.12.4 Licensing & partnership

Chapter 4 Anatomic Pathology : Competitive Analysis
4.1 Company Categorization
4.2 Recent Developments & Impact Analysis, by Key Market Participants
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.1.1 Enzifarma
4.3.1.2 Abacus ALS
4.3.1.3 Sanbio B.V.
4.3.1.4 Syntec Scientific
4.3.1.5 VWR International, LLC
4.3.1.6 MetaGene Pty Ltd.
4.3.1.7 Immuno Diagnostic OY
4.3.1.8 DSS Imagetech
4.3.1.9 Fisher Scientific
4.3.1.10 IEPSA Diagnostics
4.3.2 Key customers
4.3.3 Key player positioning analysis, 2018
4.3.3.1 Product portfolio
4.3.3.2 Market penetration
4.3.3.3 Strategic initiatives
4.3.3.4 Segment coverage
4.3.3.5 Geographical presence
4.3.3.6 Conclusion

Chapter 5 Anatomic Pathology Market Categorization: Product & Service Estimates & Trend Analysis
5.1 Anatomic Pathology Market: Product & Service Movement Analysis
5.2 Instruments
5.2.1 Global anatomic pathology instruments market, 2014 - 2025 (USD Million)
5.2.2 Microtomes & cryostat
5.2.2.1 Global microtomes & cryostat market for anatomic pathology, 2014 - 2025 (USD Million)
5.2.3 Tissue processor
5.2.3.1 Global tissue processor market for anatomic pathology, 2014 - 2025 (USD Million)
5.2.4 Automatic stainers
5.2.4.1 Global automatic stainers market for anatomic pathology, 2014 - 2025 (USD Million)
5.2.5 Other products
5.2.5.1 Global other instruments market for anatomic pathology, 2014 - 2025 (USD Million)
5.3 Consumables
5.3.1 Global anatomic pathology consumables market, 2014 - 2025 (USD Million)
5.3.2 Reagents & antibodies
5.3.2.1 Global reagents & antibodies market for anatomic pathology, 2014 - 2025 (USD Million)
5.3.3 Probes & kits
5.3.3.1 Global probes & kits market for anatomic pathology, 2014 - 2025 (USD Million)
5.3.4 Others
5.3.4.1 Global others market for anatomic pathology, 2014 - 2025 (USD Million)
5.4 Services
5.4.1 Global anatomic pathology services market, 2014 - 2025 (USD Million)

Chapter 6 Anatomic pathology Market Categorization: Application Estimates & Trend Analysis
6.1 Anatomic pathology Market: Application Movement Analysis
6.2 Disease Diagnosis
6.2.1 Global anatomic pathology market for disease diagnosis, 2014 - 2025 (USD Million)
6.3 Drug Discovery and Development
6.3.1 Global anatomic pathology market for drug discovery and development , 2014 - 2025 (USD Million)
6.4 Others
6.4.1 Global anatomic pathology market for others, 2014 - 2025 (USD Million)

Chapter 7 Anatomic Pathology Market Categorization: End-use Estimates & Trend Analysis
7.1 Anatomic Pathology Market: End-use Movement Analysis
7.2 Hospitals
7.2.1 Global anatomic pathology market for hospitals, 2014 - 2025 (USD Million)
7.3 Research Laboratories
7.3.1 Global anatomic pathology market for research laboratories, 2014 - 2025 (USD Million)
7.4 Diagnostic Laboratories
7.4.1 Global anatomic pathology market for diagnostic laboratories, 2014 - 2025 (USD Million)
7.5 Others
7.5.1 Global anatomic pathology market for others, 2014 - 2025 (USD Million)

Chapter 8 Anatomic Pathology Market Categorization: Regional Estimates & Trend Analysis, by Product & Service, Application, & End-use
8.1 Anatomic Pathology Market Share By Regional, 2018 & 2025
8.2 North America
8.2.1 North America anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.2.2 North America anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.2.3 North America anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.2.4 U.S.
8.2.4.1 U.S. anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.2.4.2 U.S. anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.2.4.3 U.S. anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.2.5 Canada
8.2.5.1 Canada anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.2.5.2 Canada anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.2.5.3 Canada anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Europe anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.3.2 Europe anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.3.3 Europe anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.3.4 Germany
8.3.4.1 Germany anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.3.4.2 Germany anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.3.4.3 Germany anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.3.5 U.K.
8.3.5.1 U.K. anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.3.5.2 U.K. anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.3.5.3 U.K. anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.4.2 Asia Pacific anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.4.3 Asia Pacific anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.4.4 China
8.4.4.1 China anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.4.4.2 China anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.4.4.3 China anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.4.5 India
8.4.5.1 India anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.4.5.2 India anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.4.5.3 India anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.5.2 Latin America anatomic pathology market, by application,2014 - 2025 (USD Million)
8.5.3 Latin America anatomic pathology market, by end-use,2014 - 2025 (USD Million)
8.5.4 Brazil
8.5.4.1 Brazil anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.5.4.2 Brazil anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.5.4.3 Brazil anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.5.5 Mexico
8.5.5.1 Mexico anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.5.5.2 Mexico anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.5.5.3 Mexico anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.6 Middle East & Africa (MEA)
8.6.1 MEA anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.6.2 MEA anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.6.3 MEA anatomic pathology market, by end-use, 2014 - 2025 (USD Million)
8.6.4 South Africa
8.6.4.1 South Africa anatomic pathology market, by product & services, 2014 - 2025 (USD Million)
8.6.4.1 South Africa anatomic pathology market, by application, 2014 - 2025 (USD Million)
8.6.4.1 South Africa anatomic pathology market, by end-use, 2014 - 2025 (USD Million)

Chapter 9 Anatomic Pathology Market: Competitive Landscape
9.1 Strategy Framework
9.2 Market Participant Categorization
9.3 Company Profiles
9.3.1 Thermo Fisher Scientific Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Quest Diagnostics Incorporated
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Laboratory Corporation of America Holdings
9.3.3.1 Company overview
9.3.3.2 Dianon Systems, Inc.
9.3.3.2.1 Company overview
9.3.3.3 Financial performance
9.3.3.4 Product benchmarking
9.3.3.5 Strategic initiatives
9.3.4 F. Hoffmann-La Roche Ltd.
9.3.4.1 Company overview
9.3.4.2 Ventana Medical Systems, Inc.
9.3.4.2.1 Company overview
9.3.4.3 Financial performance
9.3.4.4 Product benchmarking
9.3.4.5 Strategic initiatives
9.3.5 Agilent Technologies, Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Cardinal Health
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Sakura Finetek USA, Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 NeoGenomics Laboratories, Inc.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 BioGenex
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Bio SB
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.4 List of Companies
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Thermo Fisher Scientific Inc.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Dianon Systems, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Ventana Medical Systems, Inc.
  • Agilent Technologies, Inc.
  • Cardinal Health
  • Sakura Finetek USA, Inc
  • NeoGenomics Laboratories, Inc.
  • BioGenex
  • Bio SB
Note: Product cover images may vary from those shown
Adroll
adroll